Nanosystems L.L.C.
Records under this name other than patents Nanosystems L.L.C. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,521,068 | Dry powder aerosols of nanoparticulate drugs Formerly held Term ended Term ended Nov 11, 2021 · From the USPTO record | Term ended | Term ended Nov 11, 2021 | From the USPTO record |
| US 6,267,989 | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions Formerly held Term ended Term ended Mar 8, 2019 · From the USPTO record | Term ended | Term ended Mar 8, 2019 | From the USPTO record |
| US 6,153,225 | Injectable formulations of nanoparticulate naproxen Formerly held Term ended Term ended Aug 13, 2018 · From the USPTO record | Term ended | Term ended Aug 13, 2018 | From the USPTO record |
| US 6,384,519 | Micro-dynode integrated electron multiplier Formerly held Term ended Term ended Oct 30, 2017 · From the USPTO record | Term ended | Term ended Oct 30, 2017 | From the USPTO record |
| US 6,264,922 | Nebulized aerosols containing nanoparticle dispersions Formerly held Term ended Term ended Oct 9, 2017 · From the USPTO record | Term ended | Term ended Oct 9, 2017 | From the USPTO record |
| US 6,045,829 | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers Formerly held Term ended Term ended Jul 9, 2017 · From the USPTO record | Term ended | Term ended Jul 9, 2017 | From the USPTO record |
| US 6,045,677 | Microporous microchannel plates and method of manufacturing same Formerly held Term ended Term ended Feb 27, 2017 · From the USPTO record | Term ended | Term ended Feb 27, 2017 | From the USPTO record |
| US 6,432,381 | Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract Formerly held Lapsed on the fee record Ended Aug 13, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2014 | From the USPTO record |
| US 6,270,806 | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions Formerly held Lapsed on the fee record Ended Aug 7, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 7, 2013 | From the USPTO record |
| US 6,221,400 | Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors Formerly held Lapsed on the fee record Ended Apr 24, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2013 | From the USPTO record |